Orchard Therapeutics Competitors and Similar CompaniesClear all
Orchard Therapeutics's competitors and similar companies include Oxford BioTherapeutics, Stealth BioTherapeutics, Verve Therapeutics and Dyno Therapeutics.
 Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. |  Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  Verve Therapeutics Verve Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease. |  Dyno Therapeutics Dyno Therapeutics is a biotechnology company that provides AI-powered gene therapies. | |
Founding Date | Founding Date 2015 | Founding Date 2004 | Founding Date 2007 | Founding Date 2018 | Founding Date 2018 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Milton, GB HQ San Jose, US | Locations Newton, US HQ Needham, US | Locations Cambridge, US HQ | Locations Watertown, US HQ |
Employees | Employees 166 | Employees 48 | Employees 592% decrease | Employees 70 | Employees 1041% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 18.4 m | Valuation ($) 506.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) £2.1m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($150.7m) (FY, 2022) | Net income (£6.5m) (FY, 2018) | Net income ($52.5m) (FY, 2021) | Net income ($198.7m) (FY, 2024) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 10m (almost 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 100m (about 4 years ago) |
Total funding raised | Total funding raised $ 310.7m | Total funding raised $ 21.6m | Total funding raised $ 100m | Total funding raised $ 152.5m | Total funding raised $ 109m |
For sources of this data, please see the company profile
View Company Profiles
Oxford BioTherapeutics
HQ
Milton, GB
Employees
48
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
View companyStealth BioTherapeutics
HQ
Newton, US
Employees
59↓ 2% decrease
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View companyVerve Therapeutics
HQ
Cambridge, US
Employees
70
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease.
View companyDyno Therapeutics
HQ
Watertown, US
Employees
104↓ 1% decrease
Dyno Therapeutics is a biotechnology company that provides AI-powered gene therapies.
View company